Nalaganje...

Gender Bias in U.S. Pediatric Growth Hormone Treatment

Growth hormone (GH) treatment of idiopathic short stature (ISS), defined as height <−2.25 standard deviations (SD), is approved by U.S. FDA. This study determined the gender-specific prevalence of height <−2.25 SD in a pediatric primary care population, and compared it to demographics of U.S....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Sci Rep
Main Authors: Grimberg, Adda, Huerta-Saenz, Lina, Grundmeier, Robert, Ramos, Mark Jason, Pati, Susmita, Cucchiara, Andrew J., Stallings, Virginia A.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2015
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4650610/
https://ncbi.nlm.nih.gov/pubmed/26057697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep11099
Oznake: Označite
Brez oznak, prvi označite!